Navigation Links
New Healthcare Franchise Opportunity Focuses on Treating Exploding Senior Population
Date:3/9/2011

CHANDLER, Ariz., March 9, 2011 /PRNewswire/ -- ActiveRx Rehabilitation, a physical therapy and medically supervised exercise business specializing in working with senior adults, is now available to franchisees who would like to enter the exploding category of active aging.

ActiveRx Development Company, Inc., based in Chandler, Arizona, will avail its franchise model to qualified operators interested in single or multi-location opportunities and regional territories in six states: Arizona, New Mexico, Utah, Nevada, Colorado and Missouri. As the company grows, franchises will be awarded in other states and nationally.

"We're helping older adults choose how they age," says Matt Essex, founder and CEO of ActiveRx Rehabilitation, who has spent the past decade developing the business model.

"ActiveRx is redefining the aging process by improving physical function and extending independence through incorporating the two things that both patients and caregivers want most—time and care in the delivery of healthcare," he adds.

ActiveRx presently operates two company-owned facilities in Scottsdale and Phoenix. A third location in Surprise, Arizona is independently owned and operated.

The business provides a high ROI potential in a low overhead and low patient volume model that fulfills a unique niche in the national healthcare continuum—an outpatient practice focused exclusively on the physical challenges of aging.

"There is truly a need for senior physical rehab services," says Don Mecsey, the first ActiveRx independent owner/operator, who opened his clinic in late 2010. "Our one-on-one care is really different."

Staffing and equipment requirements are minimal, making start-up easy, according to Essex. ActiveRx is contracted with Medicare and many insurance companies, enabling patients to utilize their insurance in a more proactive manner.

"The timing is perfect to be
'/>"/>

SOURCE ActiveRx Development Company, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. Corning, GE Healthcare to receive Technical Achievement Award from Ceramic Society
2. Lexicon to Present Clinical Data for Diabetes Drug Candidate, LX4211, at Two Major Healthcare Conferences
3. Inventor honored for tech improving access to clean water, healthcare, and business development in India
4. The Full Yield, Inc. Launches Breakthrough Collaboration to Put Food Back at the Heart of Healthcare
5. TGen-Scottsdale Healthcare researchers make breakthrough in lung cancer
6. GE Healthcare to evaluate and develop novel imaging technology
7. Scott & White Healthcare researcher finds success with new anti-cancer drug
8. Scott & White Healthcare researcher finds success with new anti-cancer drug
9. GE Healthcare President & CEO, Mark Vachon, to Present at BioConference Live
10. TGen Clinical Research Services at Scottsdale Healthcare and Mayo Clinic study new cancer drug
11. Phoenix conference highlights TGens and Scottsdale Healthcares contributions to molecular oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... July 9, 2014 The widespread adoption ... large part by meaningful use and related federal ... interact with laboratory information. Now, more than ever, ... of clinical informatics in order to deliver high ... address the educational needs of pathologists in this ...
(Date:7/10/2014)... The vegetable oil found in your popcorn or soap might ... get even worse, according to an analysis in the Cell ... The growing demand for vegetable oil has already led to ... bringing trouble for orangutans in particular. If guidelines are not ... those large-scale industrial plantations from Asia into Africa will be ...
(Date:7/10/2014)... The Marshall Institute for Interdisciplinary Research (MIIR) and ... Medicine today announced they will be partnering with ... drugs. , Under the agreement with Shanghai-based HD ... the costs and risks of discovery and development ... own any intellectual property and commercialization rights to ...
Breaking Biology News(10 mins):New Clinical Informatics Curriculum Prepares Future Pathologists 2New Clinical Informatics Curriculum Prepares Future Pathologists 3New Clinical Informatics Curriculum Prepares Future Pathologists 4Hunger for vegetable oil means trouble for Africa's great apes 2Marshall University to partner with international company in drug development venture 2
... nest boxes used to aid cavity-nesting ducks can prove to ... by University of Cincinnati Educator Associate Professor Denis Conover, of ... Arts and Sciences, when he came upon a duck nest ... The box had tipped over. Turtle corpses were strewn about ...
... The debate may largely be drawn along political lines, but ... most controversial questions in 21st century science. Writing in ... Center for Atmospheric Research, argues that the evidence for anthropogenic ... proof should lie with research which seeks to disprove the ...
... chilly inside your house, you might just turn the heater ... to a toastier and more comfortable state until it warms ... long thought cells would respond to their environment in a ... Institute of Technology (Caltech) are finding that cells can respond ...
Cached Biology News:UC research finds that a duck's boon might be a turtle's bane 2The human cause of climate change: Where does the burden of proof lie? 2Caltech researchers find pulsating response to stress in bacteria 2Caltech researchers find pulsating response to stress in bacteria 3
(Date:7/11/2014)... Research and Markets  has announced the ... Global Industry Analysis, Size, Share, Growth, Trends and Forecast ... http://photos.prnewswire.com/prnh/20130307/600769 Transfection is ... or RNA) into cells. This technology helps the cells ... protein metabolism by affecting the nuclear genes. The transfection ...
(Date:7/11/2014)... BCC Research ( http://www.bccresearch.com ) reveals in ... (PCR) TECHNOLOGY: GLOBAL MARKETS , the global market for ... billion in 2013. This is estimated to grow to ... growth rate (CAGR) of 28.6%. , New digital PCR ... possibilities within the broader PCR field. The opportunities presented ...
(Date:7/11/2014)... EPFL and the University of  Geneva  (UNIGE) ... P. Donoghue . The American neuroscientist is to head ... The new Wyss Center for Bio- and Neuro-Engineering, ... , has named as its director one of the ... founder of Brown University,s Institute for Brain Science, has ...
(Date:7/11/2014)... ON , July 11, 2014 /CNW/ - Sunovion ... approved APTIOM TM (eslicarbazepine acetate) for use as ... seizures in patients with epilepsy who are not satisfactorily ... indicated for use in patients under 18 years of ... most common neurological disorders and according to Epilepsy Canada, ...
Breaking Biology Technology:International Transfection Technology Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019 2Global Market for Digital Polymerase Chain Reaction Technology to Reach $490 Billion by 2018; Equipment Sector Accounts for the Fastest Growing Segment With 33% CAGR 2Global Market for Digital Polymerase Chain Reaction Technology to Reach $490 Billion by 2018; Equipment Sector Accounts for the Fastest Growing Segment With 33% CAGR 3John P. Donoghue is Taking the Lead at the Wyss Center and is Appointed Professor at EPFL and University of Geneva 2John P. Donoghue is Taking the Lead at the Wyss Center and is Appointed Professor at EPFL and University of Geneva 3Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 2Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 3Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 4
... Mass. and WASHINGTON, Oct. 21 Boston,Scientific Corporation ... an analysis,of nearly 7,000 patients from its TAXUS ... performance of the TAXUS(R) Express2(TM) Paclitaxel-Eluting,Coronary Stent System ... low incidences of adverse events and repeat,revascularization through ...
... New Cases of Chagas, Disease ... & Blood Transfusions, ANAHEIM, Calif., Oct. 20 In ... the first blood-screening test,for Chagas, disease, some 241 blood donations ... the parasite known to cause,this serious and potentially fatal parasitic ...
... of AACR Virtual Meeting -, LOS ANGELES, Oct. ... announced that Kathleen Danenberg, the Company,s,President and Chief Executive ... in tailoring medicine at the 2007 AACR-NCI-EORTC,International Conference on ... 22-26, 2007 at the Moscone Convention Center,West in San ...
Cached Biology Technology:ARRIVE Registry Analysis Demonstrates Continued Safety and Efficacy of TAXUS(R) Stent in Complex Real-World Patients 2ARRIVE Registry Analysis Demonstrates Continued Safety and Efficacy of TAXUS(R) Stent in Complex Real-World Patients 3ARRIVE Registry Analysis Demonstrates Continued Safety and Efficacy of TAXUS(R) Stent in Complex Real-World Patients 4Blood Donations in U.S. Testing Positive for Chagas' Disease 2Blood Donations in U.S. Testing Positive for Chagas' Disease 3Blood Donations in U.S. Testing Positive for Chagas' Disease 4Response Genetics' CEO to Discuss Advances in Optimizing Therapy through Pharmacogenomics as Part of a Series of Presentations at AACR-NCI-EORTC International Conference 2Response Genetics' CEO to Discuss Advances in Optimizing Therapy through Pharmacogenomics as Part of a Series of Presentations at AACR-NCI-EORTC International Conference 3
Hybridization Buffer 3.6 ml...
Olig2 Immunogen: Synthetic peptide from rat. Available Date: 9-19-2006...
Mouse monoclonal [0.N.305] to G protein alpha - BSA and Azide free ( Abpromise for all tested applications). Antigen: Partially purified G protein alpha from rat brain. Entrez GeneID: 2778 ...
Proteinase K Buffer 3.9 ml...
Biology Products: